Exact Mass: 468.2173
Exact Mass Matches: 468.2173
Found 313 metabolites which its exact mass value is equals to given mass value 468.2173
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Henatinib
Ruboxistaurin
1,2-Dihydro-8-hydroxyisopentanyl-2-methoxy-4-O-methylalpinumisoflavone
1,2-Dihydro-8-hydroxyisopentanyl-3-methoxy-4-O-methylalpinumisoflavone
lomerizine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
3,5-dihydroxy-6-methyl-octanoic acid 5-O-alpha-L-rhamnopyranosyl-(1->2)-alpha-L-arabinofuranoside|5-O-alpha-L-rhamnopyranosyl-(1 -> 2)-alpha-L-arabinofuranosyl 3,5-dihydroxy-6-methyl-octanoic acid
6-O-(beta-D-glucopyranosyl)-1-O-octanoyl-beta-D-glucopyranose|6-O-beta-D-glucopyranosyl-1-O-octanoyl-beta-D-glucopyranose|nonioside C
17-acetoxy-1-acetyl-10,11-dimethoxy-4-methyl-3,4-seco-cura-18,20-dien-3-one|Strychnosilin|Strychnosiline
Me glycoside,hexa-Me,6-Me ester-2-O-beta-D-Glucopyranuranuronosyl-D-mannose
(1S,4S,5R,7R,9S,10S)-9-benzoyloxy-1-(3-furoyloxy)-4-hydroxy-dihydro-beta-agarofuran
2-O-(beta-D-glucopyranosyl)-1-O-octanoyl-beta-D-glucopyranose
17-defurano-17-(2,5-dihydro-2-oxofuran-3-yl)-28-deoxonimbolide|methyl (2aR,5aR,6S,6aR,8R,9aR,10aS,10bR,10cS)-8-(2,5-dihydro-2-oxo-3-furanyl)-2a,5a,6,6a,8,9,9a,10a,10b,10c-decahydro-2a,5a,6a,7-tetramethyl-5-oxo-2H,5H-cyclopenta[d]naphtho[2,3-b:1,8-bc]difuran-6-acetate
5,3?-dihydroxy-7,4?-dimethoxy-6,8-dimethylallyl-2,3-dihydroflavonol|prenyl-isotirumalin
3-(2-hydroxypropyl)-9-(3-hydroxy-6,8-dimethyldeca-2,4,6-trienoyl)-(6aR)-6a-methyl-9,9a-dihydro-6aH-furo[2,3-h]isochromene-6,8-dione|sassafrin A
Ala His Asn Gln
Ala His Gln Asn
Ala Asn His Gln
Ala Asn Gln His
Ala Gln His Asn
Ala Gln Asn His
Cys His Ile Pro
Cys His Leu Pro
Cys His Pro Ile
Cys His Pro Leu
Cys Ile His Pro
Cys Ile Pro His
Cys Leu His Pro
Cys Leu Pro His
Cys Pro His Ile
Cys Pro His Leu
Cys Pro Ile His
Cys Pro Leu His
Phe Thr Thr Thr
Gly His Gln Gln
Gly Gln His Gln
Gly Gln Gln His
His Ala Asn Gln
His Ala Gln Asn
His Cys Ile Pro
His Cys Leu Pro
His Cys Pro Ile
His Cys Pro Leu
His Gly Gln Gln
His Ile Cys Pro
His Ile Pro Cys
His Leu Cys Pro
His Leu Pro Cys
His Asn Ala Gln
His Asn Gln Ala
His Pro Cys Ile
His Pro Cys Leu
His Pro Ile Cys
His Pro Leu Cys
His Gln Ala Asn
His Gln Gly Gln
His Gln Asn Ala
His Gln Gln Gly
Ile Cys His Pro
Ile Cys Pro His
Ile His Cys Pro
Ile His Pro Cys
Ile Pro Cys His
Ile Pro His Cys
Ile Ser Ser Tyr
Ile Ser Tyr Ser
Ile Tyr Ser Ser
Leu Cys His Pro
Leu Cys Pro His
Leu His Cys Pro
Leu His Pro Cys
Leu Pro Cys His
Leu Pro His Cys
Leu Ser Ser Tyr
Leu Ser Tyr Ser
Leu Tyr Ser Ser
Asn Ala His Gln
Asn Ala Gln His
Asn His Ala Gln
Asn His Gln Ala
Asn Gln Ala His
Asn Gln His Ala
Pro Cys His Ile
Pro Cys His Leu
Pro Cys Ile His
Pro Cys Leu His
Pro His Cys Ile
Pro His Cys Leu
Pro His Ile Cys
Pro His Leu Cys
Pro Ile Cys His
Pro Ile His Cys
Pro Leu Cys His
Pro Leu His Cys
Gln Ala His Asn
Gln Ala Asn His
Gln Gly His Gln
Gln Gly Gln His
Gln His Ala Asn
Gln His Gly Gln
Gln His Asn Ala
Gln His Gln Gly
Gln Asn Ala His
Gln Asn His Ala
Gln Gln Gly His
Gln Gln His Gly
Ser Ile Ser Tyr
Ser Ile Tyr Ser
Ser Leu Ser Tyr
Ser Leu Tyr Ser
Ser Ser Ile Tyr
Ser Ser Leu Tyr
Ser Ser Tyr Ile
Ser Ser Tyr Leu
Ser Thr Val Tyr
Ser Thr Tyr Val
Ser Val Thr Tyr
Ser Val Tyr Thr
Ser Tyr Ile Ser
Ser Tyr Leu Ser
Ser Tyr Ser Ile
Ser Tyr Ser Leu
Ser Tyr Thr Val
Ser Tyr Val Thr
Thr Phe Thr Thr
Thr Ser Val Tyr
Thr Ser Tyr Val
Thr Thr Phe Thr
Thr Thr Thr Phe
Thr Val Ser Tyr
Thr Val Tyr Ser
Thr Tyr Ser Val
Thr Tyr Val Ser
Val Ser Thr Tyr
Val Ser Tyr Thr
Val Thr Ser Tyr
Val Thr Tyr Ser
Val Tyr Ser Thr
Val Tyr Thr Ser
Tyr Ile Ser Ser
Tyr Leu Ser Ser
Tyr Ser Ile Ser
Tyr Ser Leu Ser
Tyr Ser Ser Ile
Tyr Ser Ser Leu
Tyr Ser Thr Val
Tyr Ser Val Thr
Tyr Thr Ser Val
Tyr Thr Val Ser
Tyr Val Ser Thr
Tyr Val Thr Ser
Ruboxistaurin
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D004791 - Enzyme Inhibitors
(R)-(+)-2,2-Bis[di(3,5-di-t-butylphenyl)phosphino]-6,6-dimethoxy-1,1-biphenyl,min.
beta-D-Fructofuranosyl 6-O-octanoyl-alpha-D-glucopyranoside
(1S,12R,23R)-16-acetyl-12-methyl-23-(2-methylbut-3-en-2-yl)-3,11,14,16-tetrazahexacyclo[12.10.0.02,11.04,9.015,23.017,22]tetracosa-2,4,6,8,17,19,21-heptaene-10,13-dione
2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-hydroxy-5-phosphonopentanoic acid
2-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-5-(2-hydroxy-3-morpholin-4-ylpropyl)-3-methyl-1,6,7,8-tetrahydropyrrolo[3,2-c]azepin-4-one
1-[(6,7-dimethoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-(4-fluorophenyl)-1-[2-(1-pyrrolidinyl)ethyl]urea
2-[(2R,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
Leu-Ser-Ser-Tyr
A tetrapeptide composed of L-leucine, two L-serine units and L-tyrosine joined in sequence by peptide linkages.
3-[(4R,5R)-4-carbamoyl-2-[4-(3-hydroxypropoxy)phenyl]-5-phenyl-5H-oxazol-4-yl]propanoic acid tert-butyl ester
2-[(2R,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(2R,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(2R,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
[(1S)-1-(hydroxymethyl)-7-methoxy-1-(phenylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(3-pyridinyl)methanone
2-[(2S,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(2S,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(2S,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(2S,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
[(8R,9S,10R)-9-[4-(3-methoxyprop-1-ynyl)phenyl]-6-(2-methylphenyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(1R)-1-(hydroxymethyl)-7-methoxy-1-(phenylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(3-pyridinyl)methanone
BAY-3827
BAY-3827 is a potent and selective AMPK inhibitor with IC50 values of 1.4 nM at low (10 μM ATP concentration) and 15 nM at high (2 mM ATP concentration). BAY-3827 shows over 500-fold selectivity for most of the 331 kinases. BAY-3827 prevents phosphorylation of acetyl-CoA carboxylase 1 and shows strongest anti-proliferative activity in androgen-dependent prostate cancer cell lines[1].